Study of Bacterial L-asparaginase and Molecular expression of l-asparaginase gene in Escherichia coli

Authors

  • Dr. Luay Mannaa Ibrahim Northern technical university / Al-dour technical institute Author

DOI:

https://doi.org/10.61841/1cvjph50

Abstract

 E. coli remains highly active even after it is removed from the blood, possibly by
sequestration by liver cells) the half-life of the enzyme is increased when lymphoma cells
are implanted in guinea pigs. Since then, several microorganisms were evaluated to
obtain an L-asparaginase with greater antitumor activity compared to that produced by E.
coli and that was produced in an economically viable way. It is considered that the new
L-asparaginases to be used as medication must have pharmacological activity causing
minimal side effects. Thus, it is expected that they present a high affinity for the
substrate, a half-life time sufficient to avoid administration of several doses, low
immunogenicity and high stability. It was also postulated that a low cross-glutaminolytic
activity is important to avoid excessive side effects of the enzyme treatment. Various
information can be extracted from the simulation trajectory, such as the energy of
interaction between residues from the catalytic site of an enzyme and its substrate
(intermolecular) or interactions that one or more generated mutations may have with
neighboring residues within the protein (intramolecular) .In the Total Potential Energy
equation, we can see that the first three terms refer to: the bond length, the angles
between the atoms and the bond twist, respectively. The fourth term of the equation refers
to the calculation for non-directly bonded atoms and for atoms whose interaction is
intermolecular, thus considering the van der Waals and Coulomb interactions 

Downloads

Download data is not yet available.

References

Gomes, D. C. Biochemical and kinetic characterization of bacterial L-asparaginases and

evaluation of their cytotoxic potential, Course Conclusion Paper, Federal

University of Ceará, Fortaleza, 31 f. 2019.

Jawa, V.; Cousens, L. P.; Awwad, M.; Wakshull, E.; Kropshofer, H.;Groot, A. S. D. Tcell dependent immunogenicity of protein therapeutics: Preclinical assessment and

mitigation. Clinical Immunology, Elsevier, v. 149, p. 534–555, 2013.

Kumar, K., Verma, N., The various sources and application of L-asparaginase. Asian

Journal of Biochemical and Pharmaceutical Research, v. 2, n. 3, p. 197–205, 2012.

Lopes A. M., Oliveira-Nascimento L., De Ribeiro A., et al. Therapeutic l-asparaginase:

upstream, downstream and beyond. Crit Rev Biotechnol, v. 8551, p. 1- 18, dec.

2015.

Nelson, D.L.; COX, M.M. Lehninger's Principles of Biochemistry. 5. ed. Porto Alegre:

Artmed, 2011.

Pacheco, D.L.A. Deimmunization of L-asparaginase from Escherichia coli by Genetic

Algorithm. Course Completion Paper, Federal University of Ceará, Fortaleza, 86 f.

2019.

Salzer, W. L., Asselin, B. L., Plourde, P. V., Corn, T., Hunger SP. Development of

asparaginase Erwinia chrysanthemifor the treatmentof acute lymphoblastic

leukemia. Annals of the New York Academy of Sciences, v. 1329, p. 81–92, 2014

Shen, Y.; Maupetit, J.; Derreumaux, P.; Tuffery, P. Improved PEP-FOLD Approach for

Peptide and Miniprotein Structure Prediction. Journal of Chemical Theory and

Computation, [S.l.], v. 10, p. 4745–4758, 2014.

Verma N., Kumar K., Kaur G., Anand S. L-asparaginase: a promising chemotherapeutic

agent. Crit Rev Biotechnol, v. 27, n. 1, p. 45-62, out. 2007. Disponível em:

http://dx.doi.org/10.1080/07388550601173926.

Yao, H., Wynendaele, E., De Spiegeleer, B. Thermal sensitivity as a quality control

attribute for biotherapeutics: The L-asparaginase case. Drug Test Anal; 1–11. 2019.

Yazdi, Mehdi & Kolahi, Maryam & Foroghmand, A. & Tabandeh, Mohammad reza.

(2020). In silico assessment of plant L-asparaginase and estimating its allergenicity

in comparison to bacteria asparaginase. Pediatric Hematology/Oncology and

Immunopathology. 19. 35-46. 10.24287/1726-1708-2020-19-1-35-46.

Zhao, H.; Verma, D.; Li,W.; Choi, Y.; Ndong, C.; Fiering, S. N.; Bailey-Kellogg, C.;

Griswold, K. E. Depletion of T cell epitopes in lysostaphin mitigates anti-drug

antibody response and enhances antibacterial efficacy in vivo. Chemistry and

Biology, Elsevier, v. 22, p. 629–639, 2015.

Downloads

Published

01.10.2024

How to Cite

Study of Bacterial L-asparaginase and Molecular expression of l-asparaginase gene in Escherichia coli. (2024). International Journal of Psychosocial Rehabilitation, 25(2), 1501-1516. https://doi.org/10.61841/1cvjph50